Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein
Jessica Gasparello, Elisabetta D’Aversa, Chiara Papi, et al.
Phytomedicine (2021) Vol. 87, pp. 153583-153583
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 126
Sulfur compounds: From plants to humans and their role in chronic disease prevention
Caroline R. Hill, Armaghan Shafaei, Lois Balmer, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8616-8638
Open Access | Times Cited: 42
Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-κB Signaling in Epithelial Cells
Vivek Sharma, Prateeksha, Shailendra P. Singh, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 2, pp. 483-491
Closed Access | Times Cited: 41
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane
Solomon Habtemariam
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1169-1169
Open Access | Times Cited: 5
Preliminary results and a theoretical perspective of co‑treatment using a miR‑93‑5p mimic and aged garlic extract to inhibit the expression of the pro‑inflammatory interleukin‑8 gene
Roberto Gambari, Chiara Papi, Jessica Gasparello, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-11
Open Access
Inhibitory effects of sulforaphane on NLRP3 inflammasome activation
Cagla Kiser, Ceren Perihan Gonul, Melis Olcum, et al.
Molecular Immunology (2021) Vol. 140, pp. 175-185
Closed Access | Times Cited: 35
Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2
Zinuo Chen, Ruikun Du, Laura Cooper, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 13
Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells
Dhiraj Kumar Sah, Archana Arjunan, Seon Young Park, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 406-406
Open Access | Times Cited: 4
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2
Saba Rahimi Bahoosh, Yalda Shokoohinia, Mahdieh Eftekhari
DARU Journal of Pharmaceutical Sciences (2022) Vol. 30, Iss. 1, pp. 245-252
Open Access | Times Cited: 18
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 ‘cytokine storm’
Jessica Gasparello, Giovanni Marzaro, Chiara Papi, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 3
Open Access | Times Cited: 10
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
Plant‐derived compounds as potential leads for new drug development targeting COVID‐19
Lingxiu Liu, Maxim V. Kapralov, Mark Ashton
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1522-1554
Open Access | Times Cited: 3
Reactive Sulfur Compounds in the Fight against COVID-19
Małgorzata Iciek, Anna Bilska‐Wilkosz, Michał Kozdrowicki, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1053-1053
Open Access | Times Cited: 16
Effects of Sirolimus treatment on patients with β‐Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells
Matteo Zurlo, Francesco Nicoli, Davide Proietto, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 353-364
Open Access | Times Cited: 9
Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale
Biology (2022) Vol. 11, Iss. 2, pp. 159-159
Open Access | Times Cited: 15
Redox Regulation of Nucleotide-Binding and Oligomerization Domain-Like Receptors Inflammasome
Francesca Ferrara, Alessandra Pecorelli, Giuseppe Valacchi
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 10-12, pp. 744-770
Closed Access | Times Cited: 8
Glucoraphanin Increases Intracellular Hydrogen Sulfide (H2S) Levels and Stimulates Osteogenic Differentiation in Human Mesenchymal Stromal Cell
Laura Gambari, Marli Barone, Emanuela Amore, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 435-435
Open Access | Times Cited: 12
Identification of Potential Lead Compounds Targeting Novel Druggable Cavity of SARS-CoV-2 Spike Trimer by Molecular Dynamics Simulations
Yizhen Zhao, Yifan Zhao, Lin-Ke Xie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6281-6281
Open Access | Times Cited: 7
GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway
Zhi‐Hu Lin, Hsin Yeh, Hung-Chih Lo, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124648-124648
Open Access | Times Cited: 7
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 7
Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases
Zhenzhen Zhai, Yanxin Huang, Yawei Zhang, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1564-1564
Open Access | Times Cited: 10
Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Yifan Wang, Jing Ma, Yongfang Jiang
Cell Stress and Chaperones (2022) Vol. 28, Iss. 1, pp. 11-20
Open Access | Times Cited: 10
How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection
Kajetan Kiełbowski, Mariola Herian, Andrzej Pawlik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6377-6377
Open Access | Times Cited: 9
Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19
Shasha Liu, Baiqiao Wang, Tianran Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Protective effects of sulforaphane against toxic substances and contaminants: A systematic review.
Antonio Cascajosa-Lira, Ana I. Prieto, Silvia Pichardo, et al.
Phytomedicine (2024) Vol. 130, pp. 155731-155731
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top